RAQUEL GUARDEÑO SÁNCHEZ

Oncología de Precisión de Girona

Alsina M, Villacampa G, de Andrea C, Vivancos A, Ponz-Sarvise M, Arrazubi V, Jimenez-Fonseca P, Diez M, Sanz-Garcia E, Martínez E, Guardeño R, Calvo M, Bugés C, Longo F, Navarro V, García-Galea E, Gros A, Ochoa MC, Lopez-Janeiro A, Sanchez-Gregorio S, Herrero C, Labiano I, Vila-Casadesús M, López D, Alexandru R, Muñoz S, Tabernero J, Melero I

Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study.

CLINICAL CANCER RESEARCH, 2025, 31, 2890-2898 dx.doi.org/10.1158/1078-0432.CCR-25-0369

Epidemiología descriptiva, genética y prevención del cáncer , Oncología de Precisión de Girona , Enfermedades Digestivas y Microbiota

Serra, I, Romaguera, A, Clos, A, Valenzuela, M, Bartrolí, B, Espin, G, Núñez, CL, Guardeño, R, Trallero, J, Puigdemont, M, Sanvisens, A, Sala, M, Marcos-Gragera, R

Population study of hepatocellular carcinoma survival in northest region of Spain

JOURNAL OF HEPATOLOGY, 2025, 82

Oncología de Precisión de Girona

Negre, M, Guardeño, R, Biarnés, J, Recasens, M, Rubió, A

Lutetium-177 Dotatate Peptide Receptor Radionuclide Therapy in metastatic pheochromocytoma and paraganglioma: Experience in our center

JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36, 210-210

Oncología de Precisión de Girona

Soria A, Calvo M, Casas M, Vidales Z, Muñoz-Martínez S, Sapena V, Puigvehi M, Canillas L, Guardeño R, Gallego A, Mínguez B, Horta D, Clos A, Montoliu S, Roget M, Reig M, Vergara M

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma

Frontiers in oncology, 2022, 12, 829483-829483 dx.doi.org/10.3389/fonc.2022.829483

Oncología de Precisión de Girona

Shah MA, Udrea AA, Bondarenko I, Mansoor W, Sánchez RG, Sarosiek T, Bozzarelli S, Schenker M, Gomez-Martin C, Morgan C, Özgüroglu M, Pikiel J, Kalofonos HP, Wojcik E, Buchler T, Swinson D, Cicin I, Joseph M, Vynnychenko I, Luft AV, Enzinger PC, Salek T, Papandreou C, Tournigand C, Maiello E, Wei R, Ferry D, Gao L, Oliveira JM, Ajani JA

Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14051168

Epidemiología descriptiva, genética y prevención del cáncer , Oncología de Precisión de Girona

García-Velasco A, Zacarías-Pons L, Teixidor H, Valeros M, Liñan R, Carmona-Garcia MC, Puigdemont M, Carbajal W, Guardeño R, Malats N, Duell E, Marcos-Gragera R

Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 dx.doi.org/10.3390/ijerph17249538

Cirurgía General y Digestiva , Epidemiología descriptiva, genética y prevención del cáncer , Hematología , Nutrición, Eumetabolismo y Salud , Oncología de Precisión de Girona

Fort Culillas, R., Carmona Garcia, C., Osca Geli, G., Marcos-Gragera, R., Puigdemont Guinart, M., Biarnes Costa, J., Lopez-Ben, S., Garcia Velasco, A., Guardeno Sanchez, R.

Incidence and survival of pancreatic neuroendocrine tumours in Girona, Spain

ANNALS OF ONCOLOGY, 2020, 31, 169-169 dx.doi.org/10.1016/j.annonc.2020.04.325

Oncología de Precisión de Girona , Epidemiología descriptiva, genética y prevención del cáncer

Velasco, AG, Quintana, M, Guinart, MP, Carbajal, W, Sanchez, RG, Anna, V, Nica, A, Villavicencio, A, Vilardell, L, Marcos-Gragera, R

Incidence and trends of biliary tract cancer in Girona: A population-based study from the Girona Cancer Registry (1994-2016)

ANNALS OF ONCOLOGY, 2020, 31, 160-161 dx.doi.org/10.1016/j.annonc.2020.04.298

Oncología de Precisión de Girona

Laquente B, Macarulla T, Bugés C, Martín M, García C, Pericay C, Merino S, Visa L, Martín T, Pedraza M, Carnero B, Guardeño R, Verdaguer H, Mut A, Vilanova D, García A

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.

BMC Palliative Care, 2020, 19, 103-103 dx.doi.org/10.1186/s12904-020-00610-4

Metabolismo y Cáncer , Cirurgía General y Digestiva , Oncología de Precisión de Girona , Oncología Radioterápica y Física Médica de Girona

Puig-Costa M, Codina-Cazador A, Cortés-Pastoret E, Oliveras-Ferraros C, Cufí S, Flaquer S, Llopis-Puigmarti F, Pujol-Amado E, Corominas-Faja B, Cuyàs E, Ortiz R, Lopez-Bonet E, Queralt B, Guardeño R, Martin-Castillo B, Roig J, Joven J, Menendez JA

Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics.

Oncotarget, 2014, 5, 1942-1954 dx.doi.org/10.18632/oncotarget.1879

Directori

Publicacions

Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study.

Population study of hepatocellular carcinoma survival in northest region of Spain

Lutetium-177 Dotatate Peptide Receptor Radionuclide Therapy in metastatic pheochromocytoma and paraganglioma: Experience in our center

Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma

Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies

Incidence and Survival Trends of Pancreatic Cancer in Girona: Impact of the Change in Patient Care in the Last 25 Years

Incidence and survival of pancreatic neuroendocrine tumours in Girona, Spain

Incidence and trends of biliary tract cancer in Girona: A population-based study from the Girona Cancer Registry (1994-2016)

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.

Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics.

Formulari de contacte

Conoce el IDIBGI!